Trial · NCT04410978
Adverse events182
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
1 to 20 of 182
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | Covid-19 | Infections and infestations | Teriflunomide 14 mg | 135 | 488 | 150 |
| other | Covid-19 | Infections and infestations | Tolebrutinib 60 mg | 117 | 486 | 133 |
| other | Influenza | Infections and infestations | Teriflunomide 14 mg | 26 | 488 | 35 |
| other | Influenza | Infections and infestations | Tolebrutinib 60 mg | 19 | 486 | 24 |
| other | Nasopharyngitis | Infections and infestations | Teriflunomide 14 mg | 41 | 488 | 61 |
| other | Nasopharyngitis | Infections and infestations | Tolebrutinib 60 mg | 59 | 486 | 88 |
| other | Upper Respiratory Tract Infection | Infections and infestations | Teriflunomide 14 mg | 46 | 488 | 65 |
| other | Upper Respiratory Tract Infection | Infections and infestations | Tolebrutinib 60 mg | 46 | 486 | 69 |
| other | Urinary Tract Infection | Infections and infestations | Teriflunomide 14 mg | 27 | 488 | 32 |
| other | Urinary Tract Infection | Infections and infestations | Tolebrutinib 60 mg | 34 | 486 | 45 |
| other | Viral Upper Respiratory Tract Infection | Infections and infestations | Teriflunomide 14 mg | 34 | 488 | 48 |
| other | Viral Upper Respiratory Tract Infection | Infections and infestations | Tolebrutinib 60 mg | 31 | 486 | 54 |
| other | Neutropenia | Blood and lymphatic system disorders | Teriflunomide 14 mg | 58 | 488 | 93 |
| other | Neutropenia | Blood and lymphatic system disorders | Tolebrutinib 60 mg | 14 | 486 | 22 |
| other | Depression | Psychiatric disorders | Teriflunomide 14 mg | 27 | 488 | 27 |
| other | Depression | Psychiatric disorders | Tolebrutinib 60 mg | 11 | 486 | 11 |
| other | Headache | Nervous system disorders | Teriflunomide 14 mg | 44 | 488 | 62 |
| other | Headache | Nervous system disorders | Tolebrutinib 60 mg | 56 | 486 | 100 |
| other | Hypertension | Vascular disorders | Teriflunomide 14 mg | 27 | 488 | 28 |
| other | Hypertension | Vascular disorders | Tolebrutinib 60 mg | 16 | 486 | 19 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT04410978/events